Skip to main navigation Skip to search Skip to main content

Emalex Biosciences: A Multicenter, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Evaluate the Safety and Maintenance of Efficacy of Ecopipam in Children, Adolescents and Adults with Tourette's Disorder

Project: Research

Project Details

StatusActive
Effective start/end date08/1/2407/24/26

Funding

  • Syneos Health LLC: $59,306.10